BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 3079283)

  • 21. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
    Dini FL; Cogo R
    Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concomitant therapy with diagnostic respiratory function in the aged].
    Pleger E; Kämmer JC; Palowski H; Wendisch G
    Z Arztl Fortbild (Jena); 1990; 84(22):1153-6. PubMed ID: 2087811
    [No Abstract]   [Full Text] [Related]  

  • 23. Doxofylline: a "novofylline".
    Page CP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):231-4. PubMed ID: 20380886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline in the ambulatory treatment of chronic obstructive lung disease: resolving a controversy.
    Snider GL
    Cleve Clin J Med; 1993; 60(3):197-201. PubMed ID: 8513541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Obstructive respiratory tract diseases--new standards in therapy].
    Ulmer WT
    Fortschr Med; 1992 Nov; 110(32):595-8. PubMed ID: 1478597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning versus confirming in clinical drug development.
    Sheiner LB
    Clin Pharmacol Ther; 1997 Mar; 61(3):275-91. PubMed ID: 9084453
    [No Abstract]   [Full Text] [Related]  

  • 27. Theophylline for chronic symptomatic bradycardia in the elderly.
    Ling CA; Crouch MA
    Ann Pharmacother; 1998; 32(7-8):837-9. PubMed ID: 9681101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating dyspnea in a patient with advanced chronic obstructive pulmonary disease.
    Runo JR; Ely EW
    West J Med; 2001 Sep; 175(3):197-201. PubMed ID: 11527853
    [No Abstract]   [Full Text] [Related]  

  • 29. Acebrophylline: an airway mucoregulator and anti-inflammatory agent.
    Pozzi E
    Monaldi Arch Chest Dis; 2007 Jun; 67(2):106-15. PubMed ID: 17695695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of theophylline in the treatment of COPD.
    Ramsdell J
    Chest; 1995 May; 107(5 Suppl):206S-209S. PubMed ID: 7743828
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment and treatment of obstructive airways disease in the elderly.
    Dow I; Holgate ST
    Br Med Bull; 1990 Jan; 46(1):230-45. PubMed ID: 2405944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 33. [Theophylline in the therapy of non reversible airway obstruction].
    Drigo R; Bevilacqua M; Franco R
    G Clin Med; 1987 Jan; 68(1):39-45. PubMed ID: 3301490
    [No Abstract]   [Full Text] [Related]  

  • 34. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].
    Rabe KF; Dent G; Magnussen H
    Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe bronchial asthma improved on bamifylline. Case report and review.
    Bijl D; Speelberg B
    Respiration; 1994; 61(5):287-91. PubMed ID: 7800962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A strategy of drug treatment of obstructive respiratory tract diseases].
    Slapke J; Adolph J
    Z Arztl Fortbild (Jena); 1989; 83(17):857-9. PubMed ID: 2686213
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.